SCHEMBL31039735

SCHEMBL31039735

COCCN1CCC[C@@H](Nc2nnc(Cl)c(C)n2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 5/20 0.53
CCNE1 P24864 2/20 0.48
CDK2 P24941 2/20 0.48
CCNT1 O60563 1/20 0.48
CCNK O75909 1/20 0.48
CDK7 P50613 1/20 0.48
CDK9 P50750 1/20 0.48
CCNH P51946 1/20 0.48
MNAT1 P51948 1/20 0.48
CDK12 Q9NYV4 1/20 0.48
NLRP3 Q96P20 8/20 0.42
INSR P06213 1/20 0.36
ALK Q9UM73 1/20 0.36
CDK1 P06493 1/20 0.36
CDK4 P11802 1/20 0.36
CCNA2 P20248 1/20 0.36
CCND3 P30281 1/20 0.36
CDK6 Q00534 1/20 0.36
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31341807 0.87 ROCK2 (0.45) KAT2BNLRP3ROCK2ROCK1KDM2B
SCHEMBL27292457 0.86 NLRP3 (0.55) KAT2BCCNE1CDK2CCNT1CCNK
SCHEMBL24695702 0.84 CAMK2D (0.45) KAT2BNLRP3CAMK2D
SCHEMBL29159546 0.84 CAMK2D (0.45) KAT2BNLRP3CAMK2D
SCHEMBL31039762 0.84 NLRP3 (0.56) KAT2BCCNE1CDK2CCNT1CCNK
SCHEMBL31039740 0.82 NLRP3 (0.44) KAT2BCCNE1CDK2CCNT1CCNK
SCHEMBL31039746 0.81 NLRP3 (0.43) KAT2BNLRP3ROCK2CAMK2D
SCHEMBL25294649 0.80 KAT2B (0.45) KAT2BCCNE1CDK2CCNT1CCNK
SCHEMBL25294648 0.80 KAT2B (0.45) KAT2BCCNE1CDK2CCNT1CCNK
SCHEMBL31039733 0.79 NLRP3 (0.41) KAT2BCCNE1CDK2CCNT1CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630417-A1 NOVEL COMPOUNDS AS MODULATORS OF NLRP3 INHIBITION F. Hoffmann-La Roche AG (CH) 2025-10-15 EP disclosed
WO-2024121086-A1 NOVEL COMPOUNDS AS MODULATORS OF NLRP3 INHIBITION F. HOFFMANN-LA ROCHE AG (CH) 2024-06-13 WO disclosed